Clinical Trial Update: Fluid Resuscitation With HES 200/0.5 10% in Severe Burn Injury [Phase 3]

View source ↗

Summary

Phase 3 trial of hydroxyethyl starch 200/0.5 10% for fluid resuscitation in severe burn injuries has completed, with survival and renal failure among the outcom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burn Injuries
• Renal Failure

Drugs mentioned

• Hydroxyethyl starch 200/0.5 10% (Hydroxyethyl starch)

Snippet

Sponsor: University of Zurich | Conditions: Survival, Renal Failure | Phase 3 | Status: COMPLETED